Literature DB >> 25692914

Treatment choice for diabetic macular edema.

Daniel F Martin1, Maureen G Maguire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692914     DOI: 10.1056/NEJMe1500351

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Ophthalmic community perception of new medication needs.

Authors:  William C Stewart; Jeanette A Stewart; Lindsay A Nelson
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

Review 2.  Off-label use of targeted therapies in oncology.

Authors:  Dominique Levêque
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 3.  Ascorbic acid repletion: A possible therapy for diabetic macular edema?

Authors:  James M May
Journal:  Free Radic Biol Med       Date:  2016-02-17       Impact factor: 7.376

Review 4.  Aflibercept: A Review of Its Use in Diabetic Macular Oedema.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

5.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

6.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

7.  The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs.

Authors:  Berker Bakbak; Banu Turgut Ozturk; Saban Gonul; Sansal Gedik
Journal:  Oman J Ophthalmol       Date:  2016 Jan-Apr

8.  One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema.

Authors:  Qingyun Zhou; Chao Guo; Ailing You; Desai Wang; Wenyan Wang; Xuedong Zhang
Journal:  Mol Vis       Date:  2019-10-21       Impact factor: 2.367

9.  Approach for a Clinically Useful Comprehensive Classification of Vascular and Neural Aspects of Diabetic Retinal Disease.

Authors:  Michael D Abramoff; Patrice E Fort; Ian C Han; K Thiran Jayasundera; Elliott H Sohn; Thomas W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

10.  Changes in retinal and choriocapillaris density in diabetic patients receiving anti-vascular endothelial growth factor treatment using optical coherence tomography angiography.

Authors:  Felipe F Conti; Weilin Song; Eduardo B Rodrigues; Rishi P Singh
Journal:  Int J Retina Vitreous       Date:  2019-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.